The risks are real: no required quality control, no contamination testing, incorrect purity or peptide sequence, no physician oversight, and legal exposure for buyers who self-administer
If peptides follow a similar trajectory, increased access would likely depend on regulatory guidance and consumer demand, with distribution expanding through these same medical and wellness channels, Dr
Right now, most people cant get these compounds in a safe, controlled manner, so they get them however they can, says Abid Husain, M.D., a triple-board-certified physician specializing in peptide therapy who will be presenting at the meeting
Asian Americans and Pacific Islanders perspectives on participating in the CARE recruitment research registry for Alzheimer's disease and related dementias, aging, and caregiving research